Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 28, 2017 16:05 ET | Source: Dermira, Inc.

Dermira to Present at Needham 16th Annual Healthcare Conference

MENLO PARK, Calif., March 28, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
March 21, 2017 07:30 ET | Source: Dermira, Inc.

Dermira Presents New Data Highlighting Patient Outcomes in Axillary Hyperhidrosis at Maui Derm Meeting

MENLO PARK, Calif., March 21, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
March 17, 2017 08:30 ET | Source: Dermira, Inc.

Dermira to Highlight Data for Three Clinical Programs at Annual Maui Derm Meeting

New data for the Axillary Sweating Daily Diary patient-reported outcome instrument from the glycopyrronium tosylate Phase 2 trial in primary axillary hyperhidrosis to be highlighted Additional data...
March 07, 2017 16:05 ET | Source: Dermira, Inc.

Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

MENLO PARK, Calif., March 07, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
March 04, 2017 09:00 ET | Source: Dermira, Inc.; UCB

New CIMZIA® (certolizumab pegol) data in moderate-to-severe plaque psoriasis and psoriatic arthritis presented at American Academy of Dermatology 2017 Annual Meeting

Late-breaking, investigational 16-week data presented from the CIMPASI-1 and CIMPASI-2 trials showing CIMZIA demonstrated statistically and clinically significant improvements for patients with...
March 03, 2017 08:23 ET | Source: Dermira, Inc.

Dermira Presents New Data in Primary Axillary Hyperhidrosis and Acne at American Academy of Dermatology 2017 Annual Meeting

ORLANDO, Fla., March 03, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
March 02, 2017 16:05 ET | Source: Dermira, Inc.

Dermira to Present at Cowen and Company 37th Annual Health Care Conference

MENLO PARK, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
March 01, 2017 19:47 ET | Source: Dermira, Inc.

Dermira Prices $168.5 Million Public Offering of Common Stock

MENLO PARK, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
February 28, 2017 17:13 ET | Source: Dermira, Inc.

Dermira Announces Proposed Public Offering of Common Stock

MENLO PARK, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
February 28, 2017 16:05 ET | Source: Dermira, Inc.

Dermira Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

-- Planned submission of NDA for glycopyrronium tosylate (formerly DRM04) in 2H17 on schedule after pre-NDA meeting with FDA ---- Management to host webcast and conference call today 4:30 p.m. ET /...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right